Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine-esketamine for Sleep and Cognition in Older Adults with Cognitive Impairment
NCT07610343Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in Alzheimer's disease (AD), sleep disorders, sponsored by Peking University First Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
Alzheimer's disease (AD)sleep disorders
Beyond the preview
Go deeper on NCT07610343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07610343.